Carmen Sáez-Zea

Carmen Sáez-Zea

Auto-generated profile, based on publicly available information

Carmen Sáez-Zea

Department of Neurology, Instituto de Investigación Biosanitaria ibs, GRANADA, Hospital Universitario Virgen de las Nieves, Granada, Spain

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2011 in BMC Neurology
Verified
Journal Article
Open access
PDF file
CCCristobal Carnero-Pardo
Cristobal Carnero-Pardo
BEBeatriz Espejo-Martinez
Beatriz Espejo-Martinez
SLSamuel Lopez-Alcalde
Samuel Lopez-Alcalde
MEMaria Espinosa-Garcia
Maria Espinosa-Garcia
CSCarmen Saez-Zea
Carmen Saez-Zea
JNJose L Navarro-Espigares
Jose L Navarro-Espigares
To assess and compare the effectiveness and costs of Phototest, Mini Mental State Examination (MMSE), and Memory Impairment Screen (MIS) to screen for dementia (DEM) and cognitive impairment (CI).

2 November 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CCCristóbal Carnero-Pardo
Cristóbal Carnero-Pardo
BEBeatriz Espejo-Martínez
Beatriz Espejo-Martínez
SLSamuel López-Alcalde
Samuel López-Alcalde
MEMaría Espinosa-García
María Espinosa-García
CSCarmen Sáez-Zea
Carmen Sáez-Zea
RVRosa Vílchez-Carrillo
Rosa Vílchez-Carrillo
Illiteracy, a universal problem, limits the utilization of the most widely used short cognitive tests. Our objective was to assess and compare the effectiveness and cost for cognitive impairment (CI) and dementia (DEM) screening of three short cognitive tests applicable to illiterates. Phase III diagnostic test evaluation study was performed during one year in four Primary Care centers, prospectively including individuals with suspicion of CI or DEM. All underwent the Eurotest, Memory Alteration Test (M@T), and Phototest, applied in a balanced manner. Clinical, functional, and cognitive studies were independently performed in a blinded fashion in a Cognitive Behavioral Neurology Unit, and the gold standard diagnosis was established by consensus of expert neurologists on the basis of these results. Effectiveness of tests was assessed as the proportion of correct diagnoses (diagnostic accuracy [DA]) and the kappa index of concordance (k) with respect to gold standard diagnoses. Costs were based on public prices at the time and hospital accounts. The study included 139 individuals: 47 with DEM, 36 with CI, and 56 without CI. No significant differences in effectiveness were found among the tests. For DEM screening: Eurotest (k = 0.71 [0.59–0.83], DA = 0.87 [0.80–0.92]), M@T (k = 0.72 [0.60–0.84], DA = 0.87 [0.80–0.92]), Phototest (k = 0.70 [0.57–0.82], DA = 0.86 [0.79–0.91]). For CI screening: Eurotest (k = 0.67 [0.55–0.79]; DA = 0.83 [0.76–0.89]), M@T (k = 0.52 [0.37–0.67]; DA = 0.80 [0.72–0.86]), Phototest (k = 0.59 [0.46–0.72]; DA = 0.79 [0.71–0.86]). There were no differences in the cost of DEM screening, but the cost of CI screening was significantly higher with M@T (330.7±177.1€, mean±sd) than with Eurotest (294.1±195.0€) or Phototest (296.0±196.5€). Application time was shorter with Phototest (2.8±0.8 min) than with Eurotest (7.1±1.8 min) or M@T (6.8±2.2 min). Eurotest, M@T, and Phototest are equally effective. Eurotest and Phototest are both less expensive options but Phototest is the most efficient, requiring the shortest application time.

23 October 2012 in European Neurology
Verified
Journal Article
Closed access
PDF file
CSCarmen Sáez-Zea
Carmen Sáez-Zea
FEFrancisco Escamilla-Sevilla
Francisco Escamilla-Sevilla
MKMajed J. Katati
Majed J. Katati
AMAdolfo Mínguez-Castellanos
Adolfo Mínguez-Castellanos
Background: Subthalamic nucleus deep brain stimulation (STN-DBS) improves motor function in selected patients with Parkinson’s disease (PD) but can be associated with variable changes in cognitive functions. Methods: We studied 21 patients selected for STN-DBS and compared 6-month clinical and neuropsychological outcomes between those who underwent surgery (n = 9) and those who voluntarily refused it (n = 12). Results: Motor and quality of life outcomes were markedly superior in the STN-DBS group versus controls. A wide neuropsychological battery was administered, and the whole sample showed a statistically significant worsening in phonemic verbal fluency, time to perform the Trail Making Test part B, Digit Symbol score of WAIS-III and color-naming score of the Stroop Test. In comparison to controls, a trend to a slightly worse deterioration in phonemic verbal fluency was observed in the STN-DBS patients and was significantly correlated with reductions in the l-dopa-equivalent daily dose (r = 0.850, p = 0.007). Conclusion: Our study confirms the safety of STN-DBS from a cognitive standpoint; a reduction in verbal fluency at 6 months after surgery can also be related to PD progression and medication reduction.

1 August 2015 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
IAI. Antonio-Rubio
I. Antonio-Rubio
CNCarlos Javier Madrid Navarro
Carlos Javier Madrid Navarro
ESE. Salazar-López
E. Salazar-López
MPM.J. Pérez-Navarro
M.J. Pérez-Navarro
CSC. Sáez-Zea
C. Sáez-Zea
FEF. Escamilla-Sevilla
F. Escamilla-Sevilla

1 March 2012 in Neurología
Verified
Journal Article
Closed access
CCC. Carnero-Pardo
C. Carnero-Pardo
CSC. Sáez-Zea
C. Sáez-Zea
RCR. De la Vega Cotarelo
R. De la Vega Cotarelo
MGM. Gurpegui
M. Gurpegui

1 January 2011 in Neurología
Verified
Journal Article
Closed access
CCC. Carnero-Pardo
C. Carnero-Pardo
CSC. Sáez-Zea
C. Sáez-Zea
LML. Montiel-Navarro
L. Montiel-Navarro
IFI. Feria-Vilar
I. Feria-Vilar
MGM. Gurpegui
M. Gurpegui